← Back to Search

Remote Monitoring and Social Intervention for High Blood Pressure (E3 Trial)

N/A

Waitlist Available

Led By David A Ansell, MD, MPH

Research Sponsored by Rush University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Stage II hypertension (140/90) or greater

Be older than 18 years old

Must not have

Organ transplant recipient

Dialysis patient

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-6 month follow-up after the 12 week intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial seeks to reduce unequal high BP rates between African American & Latinx patients in Rush University Medical Center clinics.

Who is the study for?

This trial is for African American and Latinx individuals with Stage II high blood pressure (140/90 or higher) who are patients at eligible Rush University Medical Center clinics. Participants must have access to a phone or device with video capabilities.

What is being tested?

The study tests the 'E3 Remote Monitoring and Social Intervention' program, aiming to reduce racial disparities in managing high blood pressure among African American and Latinx communities.

What are the potential side effects?

Since this trial involves remote monitoring and social interventions rather than medication, traditional side effects are not applicable. However, participants may experience privacy concerns or stress related to constant health monitoring.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My blood pressure is 140/90 or higher.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have received an organ transplant.

Select...

I am on dialysis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-6 month follow-up after the 12 week intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-6 month follow-up after the 12 week intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-6 month follow-up after the 12 week intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Percentage of total participants with improvement of hypertension to below 130/80 mmHg and/or a decrease of 10mmHg in systolic readings

Percentage of total participants with sustained improvement of blood pressure below 130/80 mmHg at 3-6 month follow-up

Secondary study objectives

Correlation of change in SDOH survey score in relation to hypertension control below 130/80 mmHg

Correlation of frequency of self monitoring with post intervention ARMS survey scores

Correlation of initial SDOH survey score in relation to hypertension control below 130/80 mmHg

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Remote Blood Pressure Monitoring and Social InterventionExperimental Treatment1 Intervention

Participants are enrolled in a remote blood pressure monitoring program and social intervention composed of remote outreach from a team of community health worker, pharmacist, nurse, and social worker for 12 weeks.

0 / 3Eligibility criteria met